Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

Jaguar Financial agrees to support Gerber Scientific's acquisition of Virtek

Reading Time 1 minute read Subscribe



Jaguar Financial

On October 9, 2008, Jaguar Financial Corporation (TSX: JFC), the owner of 6,681,200 common shares of Virtek Vision International Inc. (TSX: VRK), representing approximately 19.9% of the total issued shares of Virtek, agreed to tender its shares to Gerber Scientific, Inc.'s (NYSE: GRB) offer to acquire all of the common shares of Virtek at a price of $1.05 cash per common share. Jaguar also announced that it would not be proceeding with its previously announced intention to make an offer to offer to acquire all of the shares of Virtek. Subsequently, on October 21, 2008, Gerber Scientific, Inc. announced that its wholly owned Canadian subsidiary Gerber Scientific International Ltd., had taken up 29,369,010 common shares of Virtek under the offer representing approximately 88 percent of the outstanding common shares of Virtek. Fasken Martineau advised Jaguar Financial in connection with both its offer as well as the offer by Gerber, with a team consisting of Sean Stevens (corporate) and Jeffrey Kaufman and David Hausman (litigation).



    Receive email updates from our team